Quarterly results to watch out on July 23 Quarterly results to watch out on July 23 Shohini Nath / Monday, July 22, 2019 / Article rating: 4.2 The following stocks would be in focus during Tuesday’s trading session in light of their results announcement: CRISIL, DCM Shriram, Hindustan Unilever, L&T and Praj Industries.
BHEL rises on bagging order worth Rs. 486 crore BHEL rises on bagging order worth Rs. 486 crore Shohini Nath / Monday, July 22, 2019 / Article rating: 3.8 Bharat Heavy Electricals (BHEL) has secured an order worth Rs. 486 crore for erection work of reactor side equipment of 2x1000 MWe (Units 3&4) Kudankulam Nuclear Power Project in Tamil Nadu which is being set up under foreign co-operation (Russia).
Alembic Pharma gets approval for neuropathic pain capsule Alembic Pharma gets approval for neuropathic pain capsule Geyatee Deshpande / Monday, July 22, 2019 / Article rating: 4.0 Alembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for the company’s Abbreviated New Drug Application (ANDA) Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg.
Market Close: Sensex recovers Monday blues to close down by 306 points Market Close: Sensex recovers Monday blues to close down by 306 points Gayathri Udyawar / Monday, July 22, 2019 / Article rating: 3.3 The benchmark index extended losses by dipping 305.88 points or 0.80 per cent on Monday as HDFC twins and FMCG majors dragged the index, even as Reliance and TCS provided some support.
Overnight Digest: Stocks to look out on July 23 Overnight Digest: Stocks to look out on July 23 Geyatee Deshpande / Monday, July 22, 2019 / Article rating: 3.0 The stocks to watch out on July 23 include Allied Digital, KDDL, Lauras Labs, Can Fin Homes and ICICI Securities.
Cipla gains post final USFDA approval for Pregabalin capsule Cipla gains post final USFDA approval for Pregabalin capsule Shohini Nath / Monday, July 22, 2019 / Article rating: 3.7 InvaGen Pharmaceuticals Inc, Cipla’s wholly-owned subsidiary has received final approval for its Abbreviated New Drug Application (ANDA) for Pregabalin Capsules.
Lauras Labs launches pregabalin capsules in US market Lauras Labs launches pregabalin capsules in US market Nidhi Jani / Monday, July 22, 2019 / Article rating: 5.0 Pregabalin is used to treat nerve pain in people with diabetes (diabetic neuropathy), herpes zoster (post-herpetic neuralgia), or spinal cord injury. The said medicine is also used with other medications to treat partial onset seizures in adults and children who are at least 4 years old.
Benefits of having a retirement plan Benefits of having a retirement plan Henil Shah / Monday, July 22, 2019 / Article rating: 5.0 Retirement planning is something which is generally a cornered topic in our country and many people have gathered myths regarding the same. So, what are the benefits of having a retirement plan? Let’s find out.
Ten stocks close to their 52-weeks low Ten stocks close to their 52-weeks low Shital Jibhe / Monday, July 22, 2019 / Article rating: 5.0 Following stocks are close to their 52-weeks low as at 12:54 p.m. on July 22, 2019.
Brookfield to invest in Reliance Tower Infra Trust Brookfield to invest in Reliance Tower Infra Trust Nidhi Jani / Monday, July 22, 2019 / Article rating: 5.0 Mukesh Ambani-led Reliance Industries’ subsidiary Reliance Industrial Investments has signed an agreement with BIF IV Jarvis India, an associate of Brookfield Asset Management Inc. for investment by Brookfield of Rs. 25,215 crore in the units proposed to be issued by the Tower Infrastructure Trust.